Connor, Clark & Lunn Investment Management (CC&L)
HZNP

Connor, Clark & Lunn Investment Management (CC&L)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-23,498
Closed -$2.72M – 1618
2023
Q3 		$2.72M Buy
23,498
+820
+4% +$88.1K 0.01% 534
2023
Q2 		$2.33M Sell
22,678
-57
-0.3% -$6.01K 0.01% 572
2023
Q1 		$2.48M Sell
22,735
-196
-0.9% -$21.7K 0.01% 508
2022
Q4 		$2.61M Buy
+22,931
New +$1.9M 0.02% 479
2022
Q2 		– Sell
-113,872
Closed -$12M – 1261
2022
Q1 		$12M Buy
113,872
+93,159
+450% +$9.08M 0.06% 204
2021
Q4 		$2.23M Buy
20,713
+13,880
+203% +$1.51M 0.01% 500
2021
Q3 		$748K Buy
+6,833
New +$709K ﹤0.01% 696
2021
Q2 		– Sell
-22,409
Closed -$2.06M – 1169
2021
Q1 		$2.06M Buy
+22,409
New +$1.89M 0.01% 554
2019
Q3 		– Sell
-13,775
Closed -$331K – 1162
2019
Q2 		$331K Buy
+13,775
New +$349K ﹤0.01% 806
2018
Q3 		– Sell
-61,775
Closed -$1.02M – 1169
2018
Q2 		$1.02M Buy
61,775
+17,850
+41% +$272K 0.01% 608
2018
Q1 		$624K Sell
43,925
-221,279
-83% -$3.27M ﹤0.01% 540
2017
Q4 		$3.87M Buy
265,204
+71,099
+37% +$999K 0.02% 323
2017
Q3 		$2.46M Sell
194,105
-105,445
-35% -$1.34M 0.01% 385
2017
Q2 		$3.56M Buy
+299,550
New +$3.73M 0.02% 312
2016
Q2 		– Sell
-57,225
Closed -$948K – 967
2016
Q1 		$948K Buy
57,225
+47,300
+477% +$828K 0.01% 467
2015
Q4 		$215K Buy
+9,925
New +$193K ﹤0.01% 690
2015
Q3 		– Sell
-176,800
Closed -$6.14M – 818
2015
Q2 		$6.14M Buy
+176,800
New +$5.4M 0.06% 138
2015
Q1 		– Sell
-377,100
Closed -$4.86M – 637
2014
Q4 		$4.86M Buy
377,100
+247,700
+191% +$3.1M 0.04% 158
2014
Q3 		$1.59M Buy
+129,400
New +$1.5M 0.01% 237

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s HZNP Position: Q4 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 23,498 shares — an estimated $2.72M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in HZNP in Q3 2014 and held it in 19 quarters. The position peaked at $12M in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 23,498 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.72M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 19 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $12M in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2023, filed 9 Feb 2024.